Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
Abstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These P...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | 3D Printing in Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41205-022-00134-y |
_version_ | 1798023792530817024 |
---|---|
author | Brian G. Beitler Paul F. Abraham Alyssa R. Glennon Steven M. Tommasini Lisa L. Lattanza Jonathan M. Morris Daniel H. Wiznia |
author_facet | Brian G. Beitler Paul F. Abraham Alyssa R. Glennon Steven M. Tommasini Lisa L. Lattanza Jonathan M. Morris Daniel H. Wiznia |
author_sort | Brian G. Beitler |
collection | DOAJ |
description | Abstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed devices through existing medical device regulations. However, the FDA is increasingly interested in developing guidelines and regulations specifically for PoC 3D printing due to its rapid adoption across the healthcare institutions. In this article, we review the regulatory framework that governs medical devices, discuss how PoC 3D printing falls within this framework, and describe a novel conceptual framework that the FDA has proposed. Finally, through analysis of the aforementioned regulations and discussions with industry medical 3D printing regulatory experts, we provide recommendations for PoC medical 3D printing best practices so that institutions are best positioned to utilize this revolutionary technology safely and effectively. |
first_indexed | 2024-04-11T17:52:05Z |
format | Article |
id | doaj.art-74dc26b83ed44ba593ad8982875ed057 |
institution | Directory Open Access Journal |
issn | 2365-6271 |
language | English |
last_indexed | 2024-04-11T17:52:05Z |
publishDate | 2022-02-01 |
publisher | BMC |
record_format | Article |
series | 3D Printing in Medicine |
spelling | doaj.art-74dc26b83ed44ba593ad8982875ed0572022-12-22T04:11:01ZengBMC3D Printing in Medicine2365-62712022-02-01811710.1186/s41205-022-00134-yInterpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of careBrian G. Beitler0Paul F. Abraham1Alyssa R. GlennonSteven M. Tommasini2Lisa L. Lattanza3Jonathan M. Morris4Daniel H. Wiznia5Department of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Orthopaedic Surgery, Keck School of Medicine of USCDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Radiology, The Mayo ClinicDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineAbstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed devices through existing medical device regulations. However, the FDA is increasingly interested in developing guidelines and regulations specifically for PoC 3D printing due to its rapid adoption across the healthcare institutions. In this article, we review the regulatory framework that governs medical devices, discuss how PoC 3D printing falls within this framework, and describe a novel conceptual framework that the FDA has proposed. Finally, through analysis of the aforementioned regulations and discussions with industry medical 3D printing regulatory experts, we provide recommendations for PoC medical 3D printing best practices so that institutions are best positioned to utilize this revolutionary technology safely and effectively.https://doi.org/10.1186/s41205-022-00134-y3D PrintingOrthopedicsFDAPoint-of-care (PoC) 3D PrintingMedical device design |
spellingShingle | Brian G. Beitler Paul F. Abraham Alyssa R. Glennon Steven M. Tommasini Lisa L. Lattanza Jonathan M. Morris Daniel H. Wiznia Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care 3D Printing in Medicine 3D Printing Orthopedics FDA Point-of-care (PoC) 3D Printing Medical device design |
title | Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care |
title_full | Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care |
title_fullStr | Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care |
title_full_unstemmed | Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care |
title_short | Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care |
title_sort | interpretation of regulatory factors for 3d printing at hospitals and medical centers or at the point of care |
topic | 3D Printing Orthopedics FDA Point-of-care (PoC) 3D Printing Medical device design |
url | https://doi.org/10.1186/s41205-022-00134-y |
work_keys_str_mv | AT briangbeitler interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT paulfabraham interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT alyssarglennon interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT stevenmtommasini interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT lisallattanza interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT jonathanmmorris interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare AT danielhwiznia interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare |